FDA’s food safety agenda prioritizes corporate oversight gaps while sidelining systemic reform in ultraprocessed food regulation and infant formula oversight
Original framing: “STAT+: Amid focus on food, FDA leader briefs lawmakers on priorities” — STAT News
The original framing omits the role of corporate lobbying in shaping FDA priorities, historical patterns of formula contamination (e.g., Abbott’s 2022 recall), the disproportionate impact on marginalized communities (e.g., Black and low-income families), and the lack of indigenous and traditional knowledge in food safety frameworks. It also ignores the global context of formula marketing in the Global South and the role of ultraprocessed foods in driving diet-related diseases.
Medium structural omission detected in mainstream coverage.
The narrative is produced by STAT News, a health-focused outlet with close ties to biomedical and regulatory institutions, serving policymakers, industry lobbyists, and elite health professionals. The framing centers FDA’s institutional priorities, obscuring how corporate lobbying (e.g., from formula manufacturers like Abbott) and revolving-door appointments between regulators and industry shape regulatory agendas. This serves to legitimize incremental reforms while depoliticizing the structural drivers of food insecurity and contamination.
The FDA’s current priorities echo past failures to regulate infant formula, such as the 1980s Nestlé boycott over aggressive marketing in the Global South, which led to infant malnutrition and mortality. Structural conflicts of interest have persisted since the 1970s, when the FDA’s reliance on industry-funded research began undermining public health protections. The 2022 Abbott formula recall, which sickened infants and led to shortages, is not an anomaly but a symptom of decades of deregulation and underfunding of food safety agencies. Historical parallels in pharmaceutical regulation (e.g., opioid crisis) show how revolving-door appointments between regulators and industry enable systemic failures.
The FDA’s current priorities reflect a technocratic, corporate-aligned approach to food safety that obscures the systemic failures enabling contamination and inequity in infant formula and ultraprocessed foods.